Concepedia

Holly Douglas

HD

Statistics

Publications

5

Citations

250

H-Index

5

Active since

2019

Affiliations

The Francis Crick Institute(Current)

Imperial College London

Stanford University

Howard Hughes Medical Institute

Holly Douglas is an author at The Francis Crick Institute specializing in cell death, pharmacotherapy, and drug discovery.

ORCID

Top concepts

Publications per year

2019–2021

5

Publications

5

Metabolic precision labeling enables selective probing of O-linked <i>N</i> -acetylgalactosamine glycosylation

Marjoke F. Debets, Ömür Y. Tastan, Simon Wisnovsky et al. · Proceedings of the National Academy of Sciences · 2020 · 81 citations · Full text

An essential bifunctional enzyme in <i>Mycobacterium tuberculosis</i> for itaconate dissimilation and leucine catabolism

Hua Wang, E.V. Fedorov, David M. Hunt et al. · Proceedings of the National Academy of Sciences · 2019 · 66 citations · Full text

d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition

Cesira de Chiara, Miha Homšak, Gareth A. Prosser et al. · Nature Chemical Biology · 2020 · 47 citations · Full text

, , +10

Optimization of Metabolic Oligosaccharide Engineering with Ac<sub>4</sub>GalNAlk and Ac<sub>4</sub>GlcNAlk by an Engineered Pyrophosphorylase

Anna Cioce, Ganka Bineva‐Todd, Anthony J. Agbay et al. · ACS Chemical Biology · 2021 · 39 citations · Full text

Human Mat2A Uses an Ordered Kinetic Mechanism and Is Stabilized but Not Regulated by Mat2B

Jonathan Bailey, Holly Douglas, Laura Masino et al. · Biochemistry · 2021 · 17 citations · Full text

1–5 of 5